MAPT and Alzheimer disease: Increasing evidence suggests that tau oligomers and polymers released upon neuronal apoptosis are capable of reactivating microglial cells, thus, favoring the continuous cascade of altered molecular signaling responsible for neuronal degeneration in tauopathies and AD [14].